ULTA's stock has underperformed due to competitive pressures and a challenging macroeconomic environment, resulting in lowered FY2024 guidance and negative comparable sales growth. Despite the recent ...

Read which pharmaceutical companies are addressing the risk of muscle mass loss associated with popular weight loss drugs from Novo (NOVO) and Eli Lilly (LLY).

Learn about the performance and risks of senior loan ETF FTSL, with insights into potential alternatives like CLO debt ETFs ...

Financial writer discusses F5 Inc.'s improved margins, potential growth in Q4, cautious stance on AI opportunities, and ...

Financial writer recommends buying Celsius stock (CELH) for long-term growth potential, despite short-term concerns over ...

We discuss CLS' valuation, performance metrics, and future outlook, advising caution amidst potential challenges in FY2025.

Discover how the PBoC's actions are impacting Chinese equities and why selling volatility may be a smart move in the current ...

An explainer and analysis of the shift from traditional manufacturing to tech-driven operations. Click here to read.

There are strategies to maintain income growth amidst market risks. See here for our recommendation of preferred stocks for ...

DXPE stock is a good buy with strong growth prospects and strategic acquisitions. Read here for highlights on its Q2 revenue ...

Read here for an update on the latest geopolitical tensions in the Middle East and how they are impacting oil prices and ...

Monthly payers like DIA, JEPI, JEPQ, and SPHY provide consistent income, making them attractive for income-focused investors.